Acute Hemolysis Due to Metformin in a Young Adult Treated for T-Cell Acute Lymphoblastic Leukemia
Year: 2026
Type: article
Study design: Case Report
Abstract: BACKGROUND: Patients with acute lymphoblastic leukemia (ALL) are at risk for hyperglycemia due to asparaginase, glucocorticoids, and possible underlying predisposition for glucose intolerance. The use of metformin in pediatric oncology patients is not yet widespread; however, it may be used to control blood glucose levels. OBSERVATION: We report a young adult with T-cell ALL in maintenance chemotherapy who developed hemolysis 2 weeks after starting metformin, with resolution upon cessation of metformin. CONCLUSIONS: We present this case to increase awareness of metformin-related hemolysis, review the literature, and discuss possible mechanisms for this adverse event.
Institutions: Creighton University, Stanford Medicine, Stanford University
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
OpenAlex ID: W7236817856
